Cost-Utility, sensitivity analysis - NHS perspective
HTA. A cost utility analysis of interferon beta for multiple sclerosis. Health Technology Assessment NHS R&D HTA Programme
78
A Cost-Utility Analysis of Prostate Cancer Screening in Australia
37
Type of intervention Treatment. Economic study type Cost-effectiveness analysis; cost-utility analysis.
A cost utility analysis of a rehabilitation service for people living with and beyond cancer
11
Cost-utility analysis of a dance intervention for adolescent girls with internalizing problems
9
Chiropractic integration within a community health centre: a cost description and partial analysis of cost-utility from the perspective of the institution
16
Chiropractic integration within a community health centre: a cost description and partial analysis of cost-utility from the perspective of the institution
12
Chiropractic integration within a community health centre: a cost description and partial analysis of cost-utility from the perspective of the institution
8
Chiropractic integration within a community health centre: a cost description and partial analysis of cost-utility from the perspective of the institution
11
Chiropractic integration within a community health centre: a cost description and partial analysis of cost-utility from the perspective of the institution
8
Chiropractic integration within a community health centre: a cost description and partial analysis of cost-utility from the perspective of the institution
7
Chiropractic integration within a community health centre: a cost description and partial analysis of cost-utility from the perspective of the institution
13
Comprehensive Cost-Utility Analysis of Newborn Screening Strategies
11
Cost-utility analysis of treatment methods in spinal diseases
17
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
8
Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions
11
Cost-Utility Analysis of Depot Atypical Antipsychotics for Chronic Schizophrenia in Croatia
8
Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective
8
Commentaries AN ECONOMIST’S PERSPECTIVE ON WELL-BEING ANALYSIS AND COST-BENEFIT ANALYSIS
10
Utility theory and its use in managerial systems : an NHS perspective
280